Croaker Andrew, King Graham J, Pyne John H, Anoopkumar-Dukie Shailendra, Liu Lei
Southern Cross Plant Science, Southern Cross University, Lismore, NSW 2480, Australia.
School of Medicine, The University of Queensland, St. Lucia, QLD 4072, Australia.
Int J Mol Sci. 2016 Aug 27;17(9):1414. doi: 10.3390/ijms17091414.
Sanguinaria canadensis, also known as bloodroot, is a traditional medicine used by Native Americans to treat a diverse range of clinical conditions. The plants rhizome contains several alkaloids that individually target multiple molecular processes. These bioactive compounds, mechanistically correlate with the plant's history of ethnobotanical use. Despite their identification over 50 years ago, the alkaloids of S. canadensis have not been developed into successful therapeutic agents. Instead, they have been associated with clinical toxicities ranging from mouthwash induced leukoplakia to cancer salve necrosis and treatment failure. This review explores the historical use of S. canadensis, the molecular actions of the benzophenanthridine and protopin alkaloids it contains, and explores natural alkaloid variation as a possible rationale for the inconsistent efficacy and toxicities encountered by S. canadensis therapies. Current veterinary and medicinal uses of the plant are studied with an assessment of obstacles to the pharmaceutical development of S. canadensis alkaloid based therapeutics.
加拿大血根草,也被称为血根,是一种传统药物,美洲原住民曾用它来治疗多种临床病症。这种植物的根茎含有多种生物碱,每种生物碱都针对多个分子过程发挥作用。这些生物活性化合物在机制上与该植物的民族植物学应用历史相关。尽管这些生物碱在50多年前就已被鉴定出来,但加拿大血根草的生物碱尚未被开发成成功的治疗药物。相反,它们与一系列临床毒性有关,从漱口水引起的白斑到癌症药膏坏死和治疗失败。本综述探讨了加拿大血根草的历史用途、它所含的苯并菲啶和原托品生物碱的分子作用,并探讨了天然生物碱变异,以此作为解释加拿大血根草疗法疗效和毒性不一致的一个可能原因。本文研究了该植物目前在兽医和医学上的用途,并评估了基于加拿大血根草生物碱的治疗药物在药物开发过程中所面临的障碍。